This trial is active, not recruiting.

Condition kidneys transplantation
Treatment answering specific quality of life questionnaire in kidneys transplantation population
Sponsor Assistance Publique Hopitaux De Marseille
Start date January 2012
End date March 2015
Trial size 2000 participants
Trial identifier NCT02870374, 2012-15, 2012-A00634-39


The project team developped and validated a French patient-based health-related quality of life instrument in kidney transplant: the QoL Retrans.

The aim of the study is to determine the minimum significant change of the valdiated tool: ReTransQol

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective

Primary Outcomes

Number of change in quality of life in kidneys transplantation patients using ReTransQol
time frame: 1 year

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Patient with a transplant kidney Exclusion Criteria: - Patient not able to answer survey

Additional Information

Principal investigator Stéphanie GENTILE, MD/PhD
Trial information was received from ClinicalTrials.gov and was last updated in August 2016.
Information provided to ClinicalTrials.gov by Assistance Publique Hopitaux De Marseille.